After a national search over the past six months, the Springfield Clinic board of directors has announced Rebecca Birenbaum as its new CEO, starting March 16.
Birenbaum becomes the eighth CEO in the Clinic’s 86-year history.
Birenbaum takes over for Jen Boyer, who was appointed acting CEO in December 2024 following Ray Williams’ retirement. Boyer will transition to chief operating officer.
“Jen’s exceptional operational expertise, financial insight and unwavering dedication have been pivotal in guiding the Clinic through a period of transition. The board extends its sincere appreciation for her impactful contributions, which have established a strong foundation for continued excellence and future growth,” said Chris Wottowa, chairman of the board.
Over the past seven years, Birenbaum has served as chief operating officer at Vancouver Clinic, the largest independent, physician-owned multispecialty medical practice group in the northwest. With more than 580 clinicians, 2,000 employees and 20 locations, it has many similarities to Springfield Clinic.
“Rebecca is a collaborative and strategic leader dedicated to high-quality, community-based health care,” Wottowa said. “She brings a proven record in strategic planning, physician engagement and team building, with a leadership style that is both patient-focused and accountable.”
Birenbaum has more than 25 years of experience in operations and human resources management. She received her juris doctorate from Lewis & Clark Law School, her master of business administration from American University and a bachelor’s degree from Earlham College.
“I look forward to serving as Springfield Clinic’s next CEO and partnering to lead a physician-owned organization dedicated to clinical excellence, remaining independent and caring for its employees, clinicians and the community,” Birenbaum said. “Springfield Clinic is poised to navigate the challenging health care arena and continue its commitment to improving health outcomes and providing exceptional value to those we care for.”

